ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
批准号:
3443564
负责人:
ELIOT L GARDNER
金额:
$11.61万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1994-08-31
关键词:
alcoholism antagonist alcohols behavioral medicine brain metabolism corpus striatum dopamine drug withdrawal electrochemistry electrostimulus enkephalins frontal lobe /cortex genetic strain high performance liquid chromatography laboratory rat microdialysis microinjections neuropharmacology nucleus accumbens reinforcer self stimulation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this research is to gain further insight into alcohol's
action on brain reward circuits and on dopamine
(DA) and enkephalinergic mechanisms involved in direct brain reward.
This work derives from the hypothesis that abusable substances, including
ethanol, derive part of their abuse liability from neuropharmacological
facilitation of brain reward circuits. Some workers report that
exogenous ethanol robustly lowers brain-stimulation reward thresholds,
while others report that experiential factors are additive to ethanol's
pharmacological facilitation of brain-reward. We and others have
recently found that self-administration of ethanol in laboratory rats
more robustly enhances brain reward than exogenous administration. It is
also well-established that significant genetic differences exist among
rat strains regarding alcohol preference. One alcohol-preferring strain,
the Lewis rat, is also unusually sensitive to morphine and cocaine, and
shows significantly higher preferences for morphine and cocaine than
other rat strains. We have shown that the Lewis rat is also uniquely
sensitive to the brain-reward enhancing effects of
delta(9)-tetrahydrocannabinol (delta(9)-THC), the psychoactive ingredient
in marijuana, and that this unique sensitivity to brain-reward
facilitation correlates highly with a unique sensitivity of Lewis rats to
facilitation of extracellular DA in reward-relevant loci in the nucleus
accumbens, a crucial forebrain limbic convergence of reward-related DA
circuitry. The general aim of the presently proposed work is to carry
forward and extend all these previous findings, with the hope of
identifying forebrain DA mechanisms that may correlate with high ethanol
preference, and determine whether it is possible to modulate those
mechanisms pharmacologically - thus hopefully opening up new
possibilities of pharmacotherapy for alcohol addiction and abuse. The
specific aims are to 1) study the effect of exogenously-administered
versus self-administered ethanol on extracellular DA efflux (as measured
by in vivo brain microdialysis and in vivo voltammetry) in three
reward-relevant DA forebrain loci - nucleus accumbens, medial prefrontal
cortex, and neostriatum; 2) study the effect of strain differences
(alcohol-preferring Lewis rats versus non-preferring F344 rats) on
exogenously-administered and self-administered ethanol-induced
extracellular DA efflux in these three reward-relevant DA forebrain loci;
3) study effects seen in 1) and 2) in both normal animals and
protracted-abstinence animals; and 4) study possible pharmacological
modulations (by serotonergic, DAergic, and enkephalinergic manipulations)
of effects seen in 1), 2), and 3). This application addresses specific
research needs stipulated in NIAAA Request for Applications RFA-AA-92-01
[Research on Pharmacologic Treatments for Alcoholism] and NIAAA Program
Announcement PA-91-97 [Exploratory/Developmental Grants (R21) for
Research on the Etiology of Alcoholism] ("..Goals include clarifying the
basis for alcohol craving so that more effective therapeutic agents, such
as dopaminergic agonists and serotonin uptake inhibitors, can be tested..
..Research is required to specifically delineate the potential of agents
that alter dopaminergic function..and..to identify the precise mechanisms
by which the opioid system alters drinking behavior..").
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
-
批准号:2045789
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1992
-
负责人:ELIOT L GARDNER
-
依托单位:
CLOZAPIN--CHOLINERGIC BASIS OF MESOLIMBIC SPECIFICITY
-
批准号:3428725
-
项目类别:
-
资助金额:$4.66万
-
财政年份:1988
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:2116776
-
项目类别:
-
资助金额:$18.82万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208158
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208159
-
项目类别:
-
资助金额:$15.52万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208160
-
项目类别:
-
资助金额:$14.55万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7733810
-
项目类别:
-
资助金额:$38.96万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Preclinical models
-
批准号:7733812
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Basic brain mechanisms underlying drug addiction, craving, and relapse
-
批准号:7593286
-
项目类别:
-
资助金额:$37.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7593285
-
项目类别:
-
资助金额:$37.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Pre
-
批准号:7321124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds-treating drug addiction: Preclinical
-
批准号:7149329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds for treating drug addiction: Preclinical models
-
批准号:7733811
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists-treating drug addiction
-
批准号:7149328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Basic brain mechanisms underlying drug addiction, cravin
-
批准号:7321126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction
-
批准号:7149330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors
-
批准号:7149331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for
-
批准号:7321125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7593282
-
项目类别:
-
资助金额:$46.26万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7733813
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
海外基金